Price Alert

Grace Therapeutics Inc. (GRCE)

NASDAQ: GRCE · Real-Time Price · USD

3.26

0.18 (5.84%)

At close: Aug 15, 2025, 3:59 PM

3.20

-1.83%

After-hours: Aug 15, 2025, 06:23 PM EDT

Grace Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Cash & Equivalents	20M	22.13M	11.05M	15.15M	19.39M	23M	18.55M	26.99M	21.63M	27.88M	26.24M	34.93M	38.38M	30.34M	33.01M	36.93M	40.98M
Short-Term Investments	n/a	n/a	n/a	15K	15K	n/a	6.57M	15K	15K	15K	5.01M	14K	16K	13.32M	13.31M	13.86M	16.75M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	14K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	20K	126K	301K	415K	398K	722K	959K	837K	837K	802K	778K	859K	964K	548K	238K	813K	448K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	500K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	352K	352K	352K	352K	587K	764K	778K
Total Current Assets	20.52M	22.71M	11.94M	16.06M	20.43M	24.01M	26.88M	28.89M	23.61M	29.29M	33.43M	37.51M	41.25M	45.28M	49M	54.55M	60.39M
Property-Plant & Equipment	n/a	15K	19K	21K	23K	24K	35K	57K	155K	567K	599K	632K	909K	565K	22K	43K	66K
Goodwill & Intangibles	49.27M	49.27M	49.27M	49.27M	49.27M	49.27M	49.27M	49.27M	49.27M	49.27M	82.77M	82.77M	82.77M	82.77M	65.21M	65.21M	n/a
Total Long-Term Assets	49.28M	49.28M	49.28M	49.29M	49.29M	49.29M	49.3M	49.32M	49.42M	49.83M	83.37M	83.41M	83.68M	83.34M	65.23M	65.25M	66K
Total Assets	69.81M	71.99M	61.22M	65.35M	69.72M	73.3M	76.19M	78.21M	73.03M	79.12M	116.8M	120.91M	124.93M	128.62M	114.23M	119.8M	60.45M
Account Payables	n/a	601K	665K	1.68M	1.55M	1.01M	913K	685K	607K	1.24M	3.36M	3.73M	3.06M	1.68M	2.84M	4.43M	2.28M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	24K	46K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	2.31M	n/a	814K	n/a	n/a	n/a	-24K	-46K	n/a	n/a	n/a	n/a	n/a	n/a	32K	n/a	n/a
Total Current Liabilities	2.31M	1.93M	1.97M	2.67M	2.6M	1.68M	1.77M	1.4M	1.97M	3.41M	3.43M	3.81M	3.71M	3.26M	2.9M	4.48M	2.35M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	1.63M	1.14M	3.78M	2.6M	2.96M	4.36M	3.33M	3.46M	n/a	n/a	n/a	n/a	n/a	10K	268K	1.12M	4.65M
Total Long-Term Liabilities	3.94M	3.45M	7.11M	6.54M	7.75M	9.87M	9.73M	10.07M	7.06M	7.76M	16.65M	16.94M	16.82M	17.09M	268K	1.12M	4.65M
Total Liabilities	6.25M	5.38M	9.09M	9.21M	10.35M	11.56M	11.51M	11.46M	9.02M	11.17M	20.08M	20.75M	20.53M	20.35M	3.17M	5.59M	7M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	24K	46K	80K	485K	503K	520K	819K	295K	22K	43K	66K
Common Stock	1K	1K	1K	261.04M	261.04M	261.04M	261.04M	261.04M	258.29M	258.29M	258.29M	258.29M	258.19M	257.99M	257.99M	258M	197.19M
Retained Earnings	-224.05M	-220.69M	-221.32M	-217.17M	-213.74M	-211.12M	-207.95M	-205.56M	-202.29M	-198.27M	-169.18M	-165.29M	-160.36M	-155.84M	-151.93M	-148.16M	-149.14M
Comprehensive Income	-6.04M	-6.04M	-6.04M	-6.04M	-6.04M	-6.04M	-6.04M	-6.04M	-6.04M	-6.04M	-6.04M	-6.04M	-6.04M	-6.04M	-6.53M	-6.72M	-5.57M
Shareholders Equity	63.55M	66.61M	52.14M	56.13M	59.36M	61.74M	64.68M	66.75M	64.01M	67.95M	96.72M	100.16M	104.4M	108.27M	111.06M	114.2M	53.46M
Total Investments	n/a	n/a	n/a	15K	15K	n/a	6.57M	15K	15K	15K	5.01M	14K	16K	13.32M	13.31M	13.86M	16.75M